Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04179396
Title Study of Oral Rucaparib With Other Anticancer Agents in Metastatic Castration Resistant Prostate Cancer Patients (RAMP) (RAMP)
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Clovis Oncology, Inc.

prostate adenocarcinoma

prostate carcinoma


Enzalutamide + Rucaparib

Abiraterone + Rucaparib

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.